Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly

Journal of Geriatric Psychiatry and Neurology

Volumn 9, Issue 1, 1996, Pages 13-21

  Beusterien, Kathleen M ^a   Steinwald, Bruce ^a   Ware Jr , John E ^a,b  

^a Department of Genetic and Molecular Toxicology   (United States)

^b Harvard AIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; RATING SCALE; WELLBEING;

EID: 0029921434     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879600900103     Document Type: Article

References (33)

1. Parr G, Darekar B, Fletcher A, Bulpitt CJ. Joint pain and quality of life: results of a randomized trial. Br J Clin Pharmacol 1989; 27:235-242.
2. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314:1657-1664.
3. Fletcher AE, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomized controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 1988; 2:4-7.
4. Fletcher A, Chester PC, Hawkins CMA, et al. The effects of varapamil and propanolol on quality of life in hypertension. J Hum Hypertens 1989; 3:125-130.
5. Sheikh HI, Yesavage JA, Brooks JO, et al. Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatrics 1991; 3:23-28.
6. Jamison C, Scogin F. Development of an interview-based geriatric depression scale. Int J Aging Hum Dev 1992; 35:193-204.
7. Ware JE, SnowKK, Kosinski M, Gandek B. SF-36 health status survey manual. Boston: The Health Institute, New England Medical Center, 1993.
8. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27:8217-8232.
9. Ware JE. Standards for validating health measures: definition and content. J Chron Dis 1987; 40:473-480.
10. Ware JE. Generic versus specific health status measures: Medical Outcomes Trust Bulletin. Boston: The Health Institute, New England Medical Center, March 1, 1994.
11. McHorney CA, Ware JE, Lu R, Sherbourne CD. The MOS 36-Item Short-Form Health Sruvey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 2:40-66.
12. Korner A, Nielsen BM, Eschen F, et al. Quantifying depressive symptomatology: inter-rater reliability and inter-item correlations. J Affective Disord 1990; 20:143-149.
13. Heiligenstein JH, et al. Acute effects of fluoxetine vs. placebo on functional health in late-life depression. Int Psychogeriatrics 1995; 7(suppl):125-137.
14. Ware JE, Kosinski M, Keller SD. SF-36 Physical and mental component summary measures - A User's Manual. Boston: The Health Institute, New England Medical Center, 1995.
15. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of the SF-36 Health Profile and summary measures: summary of results from the medical outcomes study. Med Care 1995; 33:AS1-16.
16. Tollefson GD, Bosomworth JC, Heiligenstein JH, et al, and Fluoxetine Collaborative Study Group. A double-blind, placebocontrolled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatrics 1995; 7:89-104.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 12:278-296.
18. Bremner JD. Fluoxetine in depressed patients: a comparison with imipramine. J Clin Psychiatry 1984; 45:414-419.
19. Stark P, Hardison D. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985; 46:53-58.
20. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
21. Likert RA. A technique for the measurement of attitudes. Arch Psyehol 1932; 140:5-55.
22. Hays RD, Hayashi T, Carson S, Ware JE. A RAND note: user's guide for the Multitrait Analysis Program (MAP). Number N-2786-RC, Santa Monica, CA: RAND Corp., November 1988.
23. Stewart AL, Ware JE. Measuring functioning and well-being: the medical outcomes study approach. Durham, NC: Duke University Press, 1992.
24. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16:297-334.
25. Nunnally JC. Psychometric theory. New York: McGraw-Hill, 1978.
26. Brink TL, Yesavage JA, Lum O, et al. Screening tests for geriatric depression. Clin Gerontologist 1982; 1:42.
27. Bech P, Allerup P, Gram LF, et al, and the Danish University Antidepressant Group. The Diagnostic Melancholia Scale: dimension of endogenous and reactive depression with relationship to the Newcastle Scales. J Affective Disord 1988; 14:161-171.
28. Chouinard G. Double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry 1985; 46:32-37.
29. Bremner JD. Fluoxetine in depressed patients: a comparison with imipramine. J Clin Psychiatry 1984; 45:414-419.
30. Noguera R, Altuna R, Alvarez E, et al. Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial. J Affective Disord 1991; 22:119-124.
31. Pond CD, Mant A, Bridges-Webb C, et al. Recognition of depression in the elderly: a comparison of general practicioner opinions and the Geriatric Depression Scale. Family Practice 1990; 7:190-194.
32. Guyatt G, Walter S, Norman Geoff. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987; 40:171-178.
33. Berwick DM, Murphy JM, Goldman PA, et al. Performance of a five-item mental health screening test. Med Care 1991; 169-176.